Niya Mansuri, weight loss expert at myBMI Wegovy 0.25 mg, FlexTouch solution for injection in pre-filled pen (2026) EMC [accessed 9 March 2026] Ozempic 0.25 mg solution for injection in pre-filled pen (2025) EMC [accessed 9 March 2026] Non-alcoholic fatty liver disease (NAFLD) (2025) NHS [accessed 9 March 2026] Sleep apnoea (2022) NHS [accessed 9 March 2026] Physical activity guidelines for adults aged 19 to 64 (2024) NHS [accessed 9 March 2026] Semaglutide for managing overweight and obesity (2023) NICE [accessed 9 March 2026] Tirzepatide for managing overweight and obesity (2025) NICE [accessed 9 March 2026] Once-weekly semaglutide 72 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial (2025) National Library of Medicine [accessed 9 March 2026] Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension (2022) National Library of Medicine [accessed 9 March 2026] Wegovy (2025) Novo Nordisk [accessed 9 March 2026] Its natural to have questions, and were here to keep things straightforward so you can stay focused on your journey
doi: 10.1210/jc.2009-2088 8 MoreiraROZaguryRLNascimentoTSZaguryL
Wegovy, made by Novo Nordisk, and Zepbound, made by Eli Lilly & Co., are in tight supply and may be hard to obtain for the next several months, according to the pharmaceutical companies
Our medical spa is located in the Watters Creek Village Shopping Center in Allen, TX
Stuenkel CA, Davis SR, Gompel A, et al
